Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial.
Lancet. 2017 Jun 10;389(10086):2317-2327. doi: 10.1016/S0140-6736(17)31429-0. Epub 2017 May 24.
Lancet. 2017.
PMID: 28551073
Clinical Trial.
How elderly rheumatoid arthritis patients respond at one year of treatment with certolizumab pegol.
Torrente-Segarra V, Fernandez Prada M, Expósito Moliner R, Garrido Puñal NP, Sánchez-Andrade Fernández A, Lamua Riazuelo JR, Olivé A, Tovar Beltrán JV; RENACER Study Group (REgistro NAcional CERtolizumab).
Torrente-Segarra V, et al.
Rheumatol Int. 2019 Feb;39(2):395-398. doi: 10.1007/s00296-018-4205-z. Epub 2018 Nov 24.
Rheumatol Int. 2019.
PMID: 30474721
No abstract available.
Item in Clipboard
Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, Randomized, Double-Blind ADMYRA Study.
Wiland P, Jeka S, Dokoupilová E, Brandt-Jürgens J, Miranda Limón JM, Cantalejo Moreira M, Cabello RV, Jauch-Lembach J, Thakur A, Haliduola H, Brueckmann I, Gaylis NB.
Wiland P, et al. Among authors: cabello rv.
BioDrugs. 2020 Dec;34(6):809-823. doi: 10.1007/s40259-020-00447-6.
BioDrugs. 2020.
PMID: 33119861
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite